Introduction
============

Elevation of the serum concentration of procalcitonin (PCT) has been proposed as a marker of disease severity and is associated with systemic infection. This association has led to the proposed use of PCT as a novel biomarker for bacterial sepsis. We sought to evaluate the PCT measurement with culture samples to quickly ratify the sepsis and rapidly begin the use of antibiotics.

Methods
=======

Between September 2006 and March 2007 we evaluated 82 blood samples from 82 patients -- 48 males (80.33 ± 10.55 years old) and 34 females (81.17 ± 13.83 years old) -- with sepsis or SIRS in the adult ICU of a tertiary hospital. The PCT levels were measured by a quantitative imunoturbidimetry method (PCTL) in ng/ml (Lumitest PCT; Brahms, Germany) and the results compared with a sample culture (blood, urine, tracheal secretion and others).

Results
=======

With the cutoff of PCT levels at 2 ng/ml and positive or negative sample cultures, the analysis found that sensitivity is 37%, specificity is 92%, positive predictive value is 0.84, negative predictive value is 0.40, positive likelihood ratio is 4.62 and negative likelihood ratio is 0.68. With the cutoff of PCT levels at 0.5 ng/ml and positive or negative sample cultures, the analysis found that sensitivity is 72%, specificity is 33%, positive predictive value is 0.54, negative predictive value is 0.48, positive likelihood ratio is 1.07 and negative likelihood ratio is 0.84.

Conclusion
==========

This preliminary analysis suggests that PCT can be used to accurately early identify sepsis only at levels above 2 ng/ml and then decide to rapidly begin the use of antibiotics. In patients with PCT \< 2 ng/ml we cannot use PCT to exclude the diagnosis of sepsis. With the cutoff of 0.5 ng/ml we found the same result. Other studies with more samples are necessary to confirm this conclusion.
